尾崎 由記範 おざき ゆきのり 先生

来歴等

略歴

2008年 東京歯科大学市川総合病院 初期研修医(〜2010年3月)
2010年 亀田総合病院腫瘍内科 後期研修医、医員(〜2014年3月)
2014年 虎の門病院 臨床腫瘍科 医員(〜2020年3月)
2020年 がん研有明病院 乳腺内科 副医長(〜現職)

論文

• 1. Pembrolizumab plus chemotherapy in triple-negative breast cancer. Lancet. 2021 Jul 3;398(10294):24.

  Masuda J, Ozaki Y, Hara F, Kitano S, Takano T.

• 2. Targeting Oncoimmune Drivers of Cancer Metastasis. Cancers 2021, 13, 554.

  Chie Kudo-Saito, Yukinori Ozaki, Hiroshi Imazeki, Hideyuki Hayashi , Jun Masuda, Hiroki Ozawa and Yamato Ogiwara.

• 3. Utility of Preoperative Computed Tomography Scans for Coronavirus Disease in a Cancer Treatment Center. S1535-6108(20)30611-5. Cancer Cell.

  Yukinori Ozaki, Jun Masuda, Akemi Kataoka, Katsunori Oikado, Natsue Uehiro, Lina Inagaki, Chieko Kato, Hidetomo Morizono, Toshimi Takano, Takayuki Ueno, Shinji, Ohno.

• 4. Sacituzumab Govitecan-hziy in Triple-Negative Breast Cancer. N Engl J Med. 2019 Jun 13;380(24):2382.

  Ozaki Y, Masuda J, Takano T.

• 5. Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review. BMC Cancer. 2019 Oct 22;19(1):980.

  Takahashi M, Ozaki Y, Kizawa R, Masuda J, Sakamaki K, Kinowaki K, Umezu T, Kondoh C, Tanabe Y, Tamura N, Miura Y, Shigekawa T, Kawabata H, Baba N, Iguchi H, Takano T.

• 6. Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study. Breast Cancer. 2018 Jan 22.

  Ozaki Y, Tanabe Y, Tamura N, Ogura T, Kondoh C, Miura Y, Yoshimura K, Kawabata H, Takano T.

• 7. Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study. BMC Cancer. 2018 Feb 5;18(1):138.

  Yukinori Ozaki, Junichi Shindoh, Wataru Gonoi, Yujiro Nishioka, Chihiro Kondoh, Yuko Tanabe, Shuichiro Matoba, Hiroya Kuroyanagi, Masaji Hashimoto and Toshimi Takano.

• 8. Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report. BMC Cancer 2017;17:778.

  Yukinori Ozaki, Junichi Shindoh, Yuji Miura, Hiromichi Nakajima, Ryosuke Oki, Miyuki Uchiyama, Jun Masuda, Keiichi Kinowaki, Chihiro Kondoh, Yuko Tanabe, Tsuyoshi Tanaka, Shusuke Haruta, Masaki Ueno, Shigehisa Kitano, Takeshi Fujii, Harushi Udagawa, Toshimi Takano.

• 9. Ewing sarcoma of the liver with multilocular cystic mass formation: a case report. BMC Cancer. 2015 Jan 22;15(1):16.

  Ozaki Y, Miura Y, Koganemaru S, Suyama K, Inoshita N, Fujii T, Hashimoto M, Tamura T, Takeuchi K, Takano T.

• 10. Resistance to androgen-pathway drugs in prostate cancer. N Engl J Med. 2014 Dec 4;371(23):2233-4.

  Ozaki Y, Miura Y, Takano T.

著書

• 1. 高野 利実, 尾崎 由記範 編集. 改訂第2版 ハイリスクがん患者の化学療法ナビゲーター. MEDICAL VIEW. 2017年10月27日出版.

受賞

• 1. 2019日本乳癌学会関東地方会 地域奨励賞

• 2. 2019 SABCS Travel Grant, 日本乳癌学会

• 3. 2020 Reviewer賞, 日本乳癌学会

• 4. 2020 JBCS Young Investigator Grant for SABCS.